Automated ambulatory blood pressure (BP) monitoring over a 24-hour period may be considered medically necessary for individuals with elevated office BP when performed 1 time to differentiate between «white coat hypertension» and true hypertension, and when the following conditions are met (see Policy Guidelines section for considerations in pediatric patients):
Office BP elevation is in the mild-to-moderate range (<180/110 mm Hg), not requiring immediate treatment with medications; and There is an absence of hypertensive end-organ damage on physical examination and laboratory testing. All other uses of ambulatory BP monitoring for individuals with elevated office BP are considered investigational, including but not limited to repeated testing in individuals with persistently elevated office BP and monitoring of treatment effectiveness.
